Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
All claims against the company in the litigation have now been dismissed.
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The investment will enable the company to enter European markets as well as enhance margins in current markets
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Move to increase affordability and accessibility for heart failure patients across the country
This product is based on Osmotic Controlled Release Oral Delivery System technology
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
Subscribe To Our Newsletter & Stay Updated
